Study on low back pain

Clinical efficacy of combination of Hijamah bil shurt (Wet cupping) followed by Dalk (Massage) with Roghan-e-Dafli and Inkebab (vapor therapy) with Tukhm-e-Soya in cases of Waj-ul-Zahr (Non-specific Low back pain) â?? An open prospective pilot clinical trial.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012112

Enrollment

Registered

2018-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M259- Joint disorder, unspecified Health Condition 2: null- Low back pain for 4 weeks or more 18 to 50 years of age of both gender

Interventions

Intervention1: Single Arm Trial With Wet Cupping Massage and Vapourisation: Wet Cupping on Day 1 And 8 With Subsequent Rest on next Day Massage And Vapourisation for 10 Days From Day 3 TO 7 AND 10 TO

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender. 2. Patients in the age group of 18-50 years 3. Clinically diagnosed patients with low back pain persisting for 4 weeks or more as chief complaint. Characterized by intermittent, recurrent and episodic problem; and includes four type of pain: local, referred, radicular and that arising from secondary (protective) muscular spasm

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years and above 50 years of age. 2. Recent low back injury. 3. BMI 35 4. Pregnant or lactating women. 5. Spinal pathology viz; severe or progressive motor weakness or central disc prolapsed, lumbar spondylolisthesis, lumbar radiculopathy, pending litigation (e.g., workplace injury), carcinoma 6. Patients receiving concomitant drug therapy with NSAIDâ??s with wash out period of less than 7 days. 7. Any systemic illness viz; hypertension, diabetes mellitus, rheumatoid arthritis, HBV, HIV infection etc. 8. Bleeding disorders.

Design outcomes

Primary

Measure	Time frame
Reduction in disease status will be assessed by grading/ scoring of McGill Pain Questionnaire and Oswestry Pain Disability index (ODI). Timepoint: 9 MONTHS	—

Secondary

Measure	Time frame
To reduce disease burden thus improving quality of lifeTimepoint: 12 MONTHS	—

Countries

India

Contacts

Public ContactDr N Zaheer Ahmed Principal Investigator

Regional Research Institute of Unani Medicine

drnzaheer@gmail.com9884764658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026